1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in Germany

Biotechnology in Germany

  • November 2016
  • -
  • MarketLine
  • -
  • 34 pages

Summary

Table of Contents

Search Inside

Summary
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons To Buy
- What was the size of the Germany biotechnology market by value in 2016?

- What will be the size of the Germany biotechnology market in 2021?

- What factors are affecting the strength of competition in the Germany biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Germany's biotechnology market?

Key Findings
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The German biotechnology market is expected to generate total revenues of $8.7bn in 2016, representing a compound annual growth rate (CAGR) of 7% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $4.3bn, equivalent to 49.7% of the market's overall value.

There is strong interest in the German biotech industry from foreign players. Japanese Astelles Pharma has entered negotiations to buy Ganymed Pharmaceuticals in order to gain access to the highly regarded cancer antibody technology.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Agricultural Biotechnology: Emerging Technologies and Global Markets

Agricultural Biotechnology: Emerging Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Analyze existing and future agricultural biotechnology products and technologies that will be commercially important. - Receive a qualitative and quantitative description of the agricultural ...

Separation Systems for Commercial Biotechnology

Separation Systems for Commercial Biotechnology

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Explore present and future strategies within the bioseparation systems market. - Learn about the upcoming developments, the holdups and the needs of the market. - Gain an insight ...

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021. Over the years, ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.